RAW264.7 대식세포에서 LPS 매개 iNOS/NO 생성에 대한 protopanaxadiol saponin 및 protopanaxatriol saponin의 억제효과 Prototypes of Panaxadiol and Panaxatriol Saponins Suppress LPS-mediated iNOS/NO Production in RAW264.7 Murine Macrophage Cells원문보기
본 연구는 RAW264.7 세포에서 lipopolysaccharide (LPS) 처리에 의한 염증매개인자의 유도에 대한 고려인삼사포닌 분획인 20(S)-protopanaxadiol saponins (PDS)과 20(S)-protopanaxatriol saponins (PTS)의 조절효능을 탐구하였다. 이를 위해 RAW264.7 세포에 PDS 또는 PTS를 $150{\mu}g/ml$의 농도로 LPS ($10{\mu}g/ml$ 처리 이전이나 처리 이후 또는 LPS와 동시에 처리하였으며, 처리된 세포에서 nitric oxide (NO)의 방출량, 유도성 nitric oxide synthase (iNOS) 및 cyclooxygenase-2 (COX-2)의 발현 량을 분석하였다. PDS에 비하여 PTS는 RAW264.7 세포에 LPS와 동시에 처리하여 24시간 동안 배양했을 때 LPS 처리에 의해 유도된 NO의 생성을 강하게 감소시켰다. RAW264.7 세포에 LPS ($10{\mu}g/ml$를 2시간 동안 처리한 후에 PDS 또는 PTS를 $150{\mu}g/ml$ 농도로 24시간 동안 처리하면 두 인삼 사포닌 성분 모두 NO의 생성을 강하게 감소시켰다. RAW264.7 세포에 PDS 또는 PTS를 $150{\mu}g/ml$ 농도로 2시간 동안 처리한 후에 LPS ($10{\mu}g/ml$를 24시간 동안 처리했을 경우에도 두 인삼 사포닌 성분 모두 LPS 처리에 의해 유도된 NO 생성을 강하게 감소시켰다. LPS 처리에 의한 NO 생성을 저해하는 효과는 PDS에 비하여 PTS가 더 강하게 나타났다. PDS와 PTS 모두 $150{\mu}g/ml$ 처리농도에서 LPS ($10{\mu}g/ml$처리에 의해 유도된 iNOS와 COX-2의 발현 역시 상당히 감소시켰다. 따라서 본 연구의 결과는 RAW264.7 대식세포에서 PDS와 PTS 두 인삼 사포닌 성분은 LPS 처리에 의한 염증활성화에 강한 억제효과를 가지고 있음을 의미하며, 전염증성 효소인 iNOS와 COX-2 발현의 감소조절을 통하여 NO의 생성을 억제함으로써 항 염증효과가 나타남을 제시한다.
본 연구는 RAW264.7 세포에서 lipopolysaccharide (LPS) 처리에 의한 염증매개인자의 유도에 대한 고려인삼 사포닌 분획인 20(S)-protopanaxadiol saponins (PDS)과 20(S)-protopanaxatriol saponins (PTS)의 조절효능을 탐구하였다. 이를 위해 RAW264.7 세포에 PDS 또는 PTS를 $150{\mu}g/ml$의 농도로 LPS ($10{\mu}g/ml$ 처리 이전이나 처리 이후 또는 LPS와 동시에 처리하였으며, 처리된 세포에서 nitric oxide (NO)의 방출량, 유도성 nitric oxide synthase (iNOS) 및 cyclooxygenase-2 (COX-2)의 발현 량을 분석하였다. PDS에 비하여 PTS는 RAW264.7 세포에 LPS와 동시에 처리하여 24시간 동안 배양했을 때 LPS 처리에 의해 유도된 NO의 생성을 강하게 감소시켰다. RAW264.7 세포에 LPS ($10{\mu}g/ml$를 2시간 동안 처리한 후에 PDS 또는 PTS를 $150{\mu}g/ml$ 농도로 24시간 동안 처리하면 두 인삼 사포닌 성분 모두 NO의 생성을 강하게 감소시켰다. RAW264.7 세포에 PDS 또는 PTS를 $150{\mu}g/ml$ 농도로 2시간 동안 처리한 후에 LPS ($10{\mu}g/ml$를 24시간 동안 처리했을 경우에도 두 인삼 사포닌 성분 모두 LPS 처리에 의해 유도된 NO 생성을 강하게 감소시켰다. LPS 처리에 의한 NO 생성을 저해하는 효과는 PDS에 비하여 PTS가 더 강하게 나타났다. PDS와 PTS 모두 $150{\mu}g/ml$ 처리농도에서 LPS ($10{\mu}g/ml$처리에 의해 유도된 iNOS와 COX-2의 발현 역시 상당히 감소시켰다. 따라서 본 연구의 결과는 RAW264.7 대식세포에서 PDS와 PTS 두 인삼 사포닌 성분은 LPS 처리에 의한 염증활성화에 강한 억제효과를 가지고 있음을 의미하며, 전염증성 효소인 iNOS와 COX-2 발현의 감소조절을 통하여 NO의 생성을 억제함으로써 항 염증효과가 나타남을 제시한다.
This study was performed to investigate the modulatory effects of two prototypes of Panax ginseng saponin fractions, 20(S)-protopanaxadiol saponins (PDS) and 20(S)-protopanaxatriol saponins (PTS), on the induction of inflammatory mediators in lipopolysaccharide (LPS)-treated RAW264.7 murine macropha...
This study was performed to investigate the modulatory effects of two prototypes of Panax ginseng saponin fractions, 20(S)-protopanaxadiol saponins (PDS) and 20(S)-protopanaxatriol saponins (PTS), on the induction of inflammatory mediators in lipopolysaccharide (LPS)-treated RAW264.7 murine macrophage cells. For this purpose, RAW264.7 cells were treated with LPS ($10{\mu}g/ml$) before, after, or simultaneously with PDS or PTS ($150{\mu}g/ml$), and the released level of nitric oxide (NO) and expression levels of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) were evaluated. When RAW264.7 cells were treated with LPS and ginseng saponin fractions simultaneously for 24 hr, PTS, compared to PDS, more strongly attenuated the NO production induced by LPS treatment. When the cells were pretreated with LPS for 2 hr followed by PDS or PTS treatment for 24 hr, both ginseng saponins strongly reduced NO release. The pretreatment of RAW264.7 cells with PDS or PTS for 2 hr followed by LPS treatment for 24 hr significantly attenuated the LPS-induced production of NO. PTS showed stronger inhibitory potency to NO generation than PDS. Our western blot experiment showed that both PDS and PTS ($150{\mu}g/ml$) also significantly down-regulated the expressions of iNOS and COX-2 induced by LPS treatment. Our results suggest that both PDS and PTS possess strong protective effects against LPS-stimulated inflammation and that their protective effects are mediated by the suppression of NO synthesis via down-regulation of pro-inflammatory enzymes, iNOS, and COX-2 in the RAW264.7 cells.
This study was performed to investigate the modulatory effects of two prototypes of Panax ginseng saponin fractions, 20(S)-protopanaxadiol saponins (PDS) and 20(S)-protopanaxatriol saponins (PTS), on the induction of inflammatory mediators in lipopolysaccharide (LPS)-treated RAW264.7 murine macrophage cells. For this purpose, RAW264.7 cells were treated with LPS ($10{\mu}g/ml$) before, after, or simultaneously with PDS or PTS ($150{\mu}g/ml$), and the released level of nitric oxide (NO) and expression levels of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) were evaluated. When RAW264.7 cells were treated with LPS and ginseng saponin fractions simultaneously for 24 hr, PTS, compared to PDS, more strongly attenuated the NO production induced by LPS treatment. When the cells were pretreated with LPS for 2 hr followed by PDS or PTS treatment for 24 hr, both ginseng saponins strongly reduced NO release. The pretreatment of RAW264.7 cells with PDS or PTS for 2 hr followed by LPS treatment for 24 hr significantly attenuated the LPS-induced production of NO. PTS showed stronger inhibitory potency to NO generation than PDS. Our western blot experiment showed that both PDS and PTS ($150{\mu}g/ml$) also significantly down-regulated the expressions of iNOS and COX-2 induced by LPS treatment. Our results suggest that both PDS and PTS possess strong protective effects against LPS-stimulated inflammation and that their protective effects are mediated by the suppression of NO synthesis via down-regulation of pro-inflammatory enzymes, iNOS, and COX-2 in the RAW264.7 cells.
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
제안 방법
In this study, we evaluated the inhibitory effects of two Panax ginseng saponins, PDS and PTS, on the production of inflammatory mediators including nitric oxide and on the expressions of iNOS and COX-2 in LPS-stimulated RAW 264.7 murine macrophage cells. We found that both PDS and PTS inhibited LPS-induced NO generation accompanied by a reduction of iNOS level in RAW264.
To investigate the anti-inflammatory effects of PDS or PTS, RAW264.7 cells were treated with LPS (10 μg/ml) for 2 hr or 24 hr before, after or even simultaneous treatment with PDS or PTS, and the level of NO production was evaluated.
대상 데이터
7 cells were purchased from the Korean Cell Line Bank (Seoul, Korea). LPS (Escherichia coli, serotype O55:B5) was purchased from Sigma-Aldrich (St. Louis, MO, USA) and was used to induce an inflammatory response. Anti-iNOS mouse monoclonal, anti-COX-2 goat polyclonal and anti-β-actin mouse monoclonal antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Final concentrations of PDS and PTS used for experiments were prepared by diluting the stock solution with DMEM immediately before use. RAW264.7 cells were purchased from the Korean Cell Line Bank (Seoul, Korea). LPS (Escherichia coli, serotype O55:B5) was purchased from Sigma-Aldrich (St.
데이터처리
Monoclonal sheep anti-mouse IgG, or donkey anti-goat IgG horseradish peroxidase-conjugated secondary antibodies were used at 1:2,000 dilutions in TBST. Images were pictured using the Amersham Imager 600 (GE Healthcare Life Sciences) and densitometric data were calculated using the analysis program provided by the Amersham Imager 600.
Student’s t-test and a one-way ANOVA were used to determine the statistical significance of the difference between values for the various experimental and control groups.
성능/효과
In conclusion, from our results that both PDS and PTS inhibit the release and production of inflammatory mediators including NO by inhibiting the expression of pro-inflammatory enzymes, iNOS and COX-2, we suggest that both ginseng saponins may be used as auxiliary substances for treatment of pro-inflammatory diseases.
In this context, the unique modulatory effect of PDS and PTS on the control of iNOS and COX-2 expression might repre- sent a novel mechanism to strengthen adaptive immunity and inflammatory resolution. Thus, the experimental observations in this study support that both PDS and PTS specifically inhibits LPS-stimulated inflammation and mechanistically contributes to the anti-inflammation efficacy of the Panax ginseng.
후속연구
These results suggest that both PDS and PTS possess strong protective potencies to the LPS-induced cytotoxicity rather than preventive effects. Further studies are necessary to investigate its protective effect mechanistically. Based on these results, the concentrations at 150 μg/ml of PDS or PTS were applied for other experiments in this study.
Various inflammatory diseases involve inflammatory mediators such as NO and PGE2 as well as pro-inflammatory cytokines, such as TNF-α, IL-1β and IL-6, in macrophages [19, 27]. Having shown that the two ginseng saponins facilitate anti-inflammatory effect against LPS, our further study will focus on determination of their inhibitory mechanisms of pro-inflammatory cytokine signaling in macrophages.
However, the inhibitory effect of PDS or PTS on TLR-4 production in LPS-stimulated macrophages has not yet been fully reported. Therefore, further studies are necessary for elucidation of the molecular mechanism whether the reduction effects of PDS and PTS on the NO-generation system in LPS-stimulated RAW264.7 cells are involved in the inhibition of LPS binding to Toll-like receptor(s) by the two ginseng saponins.
참고문헌 (30)
Byeon, S. E., Lee, J., Kim, J. H., Yang, W. S., Kwak, Y. S., Kim, S. Y., Choung, E. S., Rhee, M. H. and Cho, J. Y. 2012. Molecular mechanism of macrophage activation by red ginseng acidic polysaccharide from Korean red ginseng. Mediators Inflamm. 2012, 732860.
Cario, E. and Podolsky, D. K. 2000. Differential alteration in intestinal epithelial cell expressionof toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect. Immun. 68, 7010-7017.
Cuzzocrea, S. and Salvemini, D. 2007. Molecular mechanisms involved in the reciprocal regulation of cyclooxygenase and nitric oxide synthase enzymes. Kidney Int. 71, 290-297.
Friedl, R., Moeslinger, T., Kopp, B. and Spieckermann, P. G. 2001. Stimulation of nitric oxide synthesis by the aqueous extract of Panax ginseng root in RAW264.7 cells. Brit. J. Pharmacol. 134, 1663-1670.
Hasegawa, H. 2004. Proof of the mysterious efficacy of ginseng: basic and clinical trials: metabolic activation of ginsenoside: deglycosylation by intestinal bacteria and esterification with fatty acid. J. Pharmacol. Sci. 95,153-157.
Hoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T. and Takeda, Y. et al. 1999. Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the LPS gene product. J. Immunol. 162, 3749-3752.
Ichikawaa, T., Li, J., Nagarkatti, P., Nagarkatti, M., Hofsethc, L. J., Windust, A. and Cui, T. 2009. American ginseng preferentially suppresses STAT/iNOS signaling in activated macrophages. J. Ethnopharmacol. 125, 145-150.
Jeong, H. G., Pokharel, Y. R., Han, E. H. and Kang, K. W. 2007. Induction of cyclooxygenase-2 by ginsenoside Rd via activation of CCAAT-enhancer binding proteins and cyclic AMP response binding protein. Biochem. Biophys. Res. Commun. 359, 51-56.
Kim, H. S. and Moon, E. Y. 2009. Reactive oxygen species-induced expression of B cell activating factor (BAFF) is independent of Toll-like receptor 4 and myeloid differentiation primary response gene 88. Biomol. Ther. 17, 144-150.
Kim, T. W., Joh, E. H., Kim, B. and Kim, D. H. 2012. Ginsenoside Rg5 ameliorates lung inflammation in mice by inhibiting the binding of LPS to toll-like receptor-4 on macrophages. Int. Immunopharmacol. 12, 110-116.
Kwak, Y. S., Kyung, J. S., Kim, J. S., Cho, J. Y. and Rhee, M. H. 2010. Anti-hyperlipidemic effects of red ginseng acidic polysaccharide from Korean red ginseng. Biol. Pharm. Bull. 33, 468-472.
Lee, K. W., Jung, S. Y., Choi, S. M. and Yang, E. J. 2012. Effects of ginsenoside Re on LPS-induced inflammatory mediators in BV2 microglial cells. BMC Complement. Altern. Med. 12, 196.
Lee, S. H., Soyoola, E., Chanmugam, P., Hart, S., Sun, W., Zhong, H., Liou, S., Simmons, D. and Hwang, D. 1992. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J. Biol. Chem. 267, 25934-25938.
Mariotto, S., Suzuki, Y., Persichini, T., Colasanti, M., Suzuki, H. and Cantoni, O. 2007. Cross-talk between NO and arachidonic acid in inflammation. Curr. Med. Chem. 14, 1940-1944.
Mathrani, V. C., Kenyon, N. J., Zeki, A. and Last, J. A. 2007. Mouse models of asthma: can they give us mechanistic insights into the role of nitric oxide? Curr. Med. Chem. 14, 2204-2213.
Ran, S. and Montgomery, K. E. 2012. Macrophage-mediated lymphangiogenesis: the emerging role of macrophages as lymphatic endothelial progenitors. Cancers (Basel) 4, 618-657.
Rossol, M., Heine, H., Meusch, U., Quandt, D., Klein, C., Sweet, M. J. and Hauschildt, S. 2011. LPS-induced cytokine production in human monocytes and macrophages. Crit. Rev. Immunol. 31, 379-446.
Salinas, G., Rangasetty, U. C., Uretsky, B. F. and Birnbaum, Y. 2007. The cycloxygenase 2 (COX-2) story: it's time to explain, not inflame. J. Cardiovasc. Pharmacol. Ther. 12, 98-111.
Tachikawa, E., Kudo, K., Harada, K., Kashimoto, T., Miyate, Y., Kakizaki, A. and Takahashi, E. 1999. Effects of ginseng saponins on responses induced by various receptor stimuli. Eur. J. Pharmacol. 369, 23-32.
Tsatsanis, C., Androulidaki, A., Venihaki, M. and Margioris, A. N. 2006. Signaling networks regulating cyclooxygenase-2. Int. J. Biochem. Cell Biol. 38, 1654-1661.
Tsoyi, K., Kim, H. J., Shin, J. S., Kim, D. H., Cho, H. J., Lee, S. S., Ahn, S. K., Yun-Choi, H. S., Lee, J. H., Seo, H. G. and Chang, K. C. 2008. HO-1 and JAK-2/STAT-1 signals are involved in preferential inhibition of iNOS over COX-2 gene expression by newly synthesized tetrahydroisoquinoline alkaloid, CKD712, in cells activated with lipopolysacchride. Cell. Signal. 10, 1839-1847.
Wu, C. F., Bi, X. L. and Yang, J. Y., et al. 2007. Differential effects of ginsenosides on NO and TNF- ${\alpha}$ production by LPS-activated N9 microglia. Int. Immunopharmacol. 7, 313-320.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.